Piramal Pharma Limited (NSE:PPLPHARMA)
India · Delayed Price · Currency is INR 245.81
+0.56 (0.23%)
Nov 12, 2026, 3:29 PM IST
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 326.75 billion as of November 12, 2026. It is the 4,659th most valuable company in the world and the 270th biggest in India. Its market cap has increased by 26.70% in one year.
Market Cap
326.75B
Enterprise Value
377.40B
Revenue
97.79B
Global Rank
Country Rank
#270 India
PE Ratio
n/a
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 326.75B, an increase of 44.11%. That is a compound annual growth rate of 9.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 325.76B | 42.46% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 633.93B |
| Gland Pharma | 546.86B |
| Ipca Laboratories | 483.31B |
| Emcure Pharmaceuticals | 442.79B |
| Ajanta Pharma | 415.66B |
| Wockhardt | 335.14B |
| Alembic Pharmaceuticals | 205.21B |
| Cohance Lifesciences | 180.76B |